QualityDipStocks / Finance · Life Insurance
Globe Life GL
Outside our quality screen, so we don’t track its dips. It’s 14% below its 52-week high.
Outside our quality screen, trading below our fair value estimate.
- Fair value est.
- $180.75+14%
- Market Value
- $159.98price −1%
- Off 52-wk high
- −14%
- Risk vs market
- Lowbeta 0.32
5 bullish · 4 bearish See why
Key levels
Every level vs today’s $159.08
- 52-wk lowlowest close, 1 year$130.37−18.0%
- PriceFri Oct 30 close$159.08you are here
- Market Valueavg paid since Oct 21$159.98+0.6%
- Fair value est.base case$180.75+13.6%
- 52-wk highhighest close, 1 year$186.02+16.9%
Fair value estimate
How the range is computed
Financials model (residual income). Same residual-income model as the base: cost of equity 9.5% ±1 point and return on equity 17.0% ±2 points. Bear = 10.5% and 15.0%; bull = 8.5% and 19.0%. A model estimate from public filings, not a forecast of where the price will go.
Price sits inside the range.
What the price implies To be worth today’s price, GL would need a return on equity of about 15% a year; our estimate uses 17%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 30 to Oct 30, 252 sessions). Beta = how much GL moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Moves much less than the market, but its own price swings are 1.6× the S&P 500’s (it moves on its own news).
- Beta vs S&P 500
- 0.32
- Volatility
- 21% vs 13% SPY
- Correlation SPY
- 0.19
- Correlation QQQ
- 0.04
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 5 of 5
ValuationOur residual-income fair value estimate is $180.75, 14% above the price.
Cash returnsShare count down 4.7% in a year: $881M of buybacks over 12 months.
ValuationP/E of 10.1× vs a 13.5× median for the 151 Finance companies we cover.
ProfitabilityReturn on equity of 21% over the last 12 months.
GrowthDiluted EPS grew 18% to $14.07 in FY2025.
Top bearish points 4 of 5
GrowthSales grew 4.7% a year over the last three fiscal years, below the 9.3% median for the 144 Finance companies we cover.
GrowthSales grew 5.2% over the last 12 months, below the 11% median for the 142 Finance companies we cover.
Cash returnsDividend yield of 0.7%, below the 2.2% median for the 132 Finance companies we cover.
QualityDoesn’t pass our quality screen: no cash-flow data.
Who’s talking about it
Notable investors, executives, analysts and public figures on Globe Life in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 1, 9:09 PM ET.
Compare with peers
Closest in size in Life Insurance
All fundamentals
P/E 10.1 · ROE 21% · Sales +5%
Valuation
- P/E
- 10.1×Finance median 13.5×
- Price / FCF
- n/acash flow isn't a clean measure for an insurer
- FCF yield
- n/acash flow isn't a clean measure for an insurer
- EV / EBITDA
- n/anot meaningful for an insurer
- Price / sales
- 1.97×
- Price / book
- 1.99×
- Market cap
- $12.2Bprice × diluted shares
- Enterprise value
- $14.7B
Growth
- Revenue, 12 months
- $6.2B
- Sales growth, 12 months
- +5.2%vs the 12 months before
- Sales growth, 3 yrs
- +4.7%/yrfrom FY2022
- Diluted EPS, 12 months
- $15.04
- EPS growth, last FY
- +17.8%
- Net income, 12 months
- $1.2B
- Net income growth
- +14%12 months vs before
Profitability
- Gross margin
- n/anot meaningful for an insurer
- Operating margin
- n/anot reported in its SEC filings
- Net margin
- 19.6%
- FCF margin
- 19.9%
- Return on equity
- 21%
- Return on invested capital
- n/anot meaningful for an insurer
Balance sheet
- Cash & short-term inv.
- $455M
- Total debt
- $2.9B
- Net cash
- n/anot meaningful for an insurer
- Debt / equity
- n/adeposits/float make debt/equity not comparable for an insurer
- Interest coverage
- n/anot meaningful for an insurer
Cash flow & returns
- Free cash flow, 12 months
- $1.2B
- FCF growth, 12 months
- −9%
- Dividend yield
- 0.74%$91M paid
- Payout ratio
- 7%
- Buybacks, 12 months
- $881M7.2% of market cap
- Share count, 1 year
- −4.7%diluted shares vs a year ago
- Stock-based comp
- $58M
Trailing 12 months to Jun 30, 2026; balance sheet at Jun 30, 2026. From Globe Life’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
Valuation details
DCF $180.75 · MV $159.98
Financials model (residual income): book value $102.51 a share on Jun 30, 2026, plus the earnings above a 9.5% cost of equity. ROE 17.0%, the average of 15.9% for the trailing 12 months to Jun 30, 2026 and 18.2% over fiscal 2021–2025, on average common equity; payout 75% of earnings (dividends 7% + net buybacks 68%), so book grows by the retained rest; the return above 9.5% fades halfway toward 9.5% over 10 years, then grows at 3% (terminal value). From the 10-Q filed Aug 5, 2026.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Momentum & 52-week range
RSI 38 · 5 days +2.8%
The business
Sales +6%
- Sales growth (latest quarter vs year-ago quarter)+6%
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.
GL is outside our quality screen
One text when a published rule fires on one of the 333 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.